Educational resources

Guidelines in Practice has developed a range of educational resources—including animations, formulary decision guides, implementation checklists, supplements, and webinars—to support you with your learning and implementation of best practice. Items may contain pharmaceutical promotional information.

Webinars

Chronic obstructive pulmonary disease: managing breathlessness

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103138 Date of preparation: November 2020

What are our options for children with severe asthma?

Commissioned by Boehringer Ingelheim Limited

The appropriate use of inhaled corticosteroids (ICS) in COPD

Commissioned by Boehringer Ingelheim Limited

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd.

Animations

Prescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

Fencino® (fentanyl transdermal patch): clinical and practical considerations

Commissioned by Ethypharm UK Ltd

This animation has been commissioned and funded by Ethypharm UK Ltd and developed in partnership with Guidelines in Practice.
Download prescribing information and adverse event statement
UK-FEN-27 Date of Preparation: November 2020

Videos

NICE guidance on respiratory conditions and COVID-19: 5-minute video

By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context

Death certification in COVID-19: 5-minute video

By Dr Toni Hazell

Dr Toni Hazell highlights important things you need to know about changes to death certification processes during the COVID-19 outbreak

Formulary decision guides

Soprobec (beclometasone dipropionate) pMDI

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 December 2020

Nutramigen* PURAMINO*

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines inPractice.
RB-M-18261 October 2020

Nutramigen* 1, 2 & 3 LGG®

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice.
RB-M-18259 October 2020

Doptelet®▼(Avatrombopag)

Commissioned by Swedish Orphan Biovitrum Ltd

This formulary decision guide was developed from content provided by Swedish Orphan Biovitrum Ltd in a format developed by Guidelines in Practice.
View prescribing information and adverse events reporting
PP-9170

Formulary decision guide: Saxenda® (liraglutide injection 3 mg)

Commissioned by Novo Nordisk

This formulary decision guide has been commissioned by Novo Nordisk. Information intended for UK healthcare professionlas only.
Click here for the Prescribing Information and Adverse Events Reporting.

UK20SX00110
Date of preparation: October 2020

Stalpex (salmeterol xinafoate/fluticasone propionate)

Commissioned by Glenmark Pharmaceuticals Europe Ltd

Supplements

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020

Showcasing local best practice in diabetes

This Guidelines in Practice supplement that aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Updates in venous thromboembolism management—a haematologist’s perspective

Commissioned by BMS – Pfizer Alliance

This supplement has been commissioned and funded by the BMS-Pfizer Alliance and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals.
View prescribing and adverse event reporting information

PP-ELI-GBR-7703 November 2020

Managing patients with type 2 diabetes— a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This supplement has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information
PC-GB-103153 November 2020

Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust

Commissioned by Celltrion Healthcare UK Ltd

This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D (1) October 2020

The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd. Information intended for healthcare professionals only.
Click here for Prescribing information and Adverse Event Reporting.

BEO20-C089b (1)
Date of preparation: October 2020